We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Ares Acquisition Corporation | NYSE:AAC | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.79 | 0 | 01:00:00 |
BRENTWOOD, Tenn., May 30, 2019 /PRNewswire/ -- In early May, Michael Cartwright, the CEO of American Addiction Centers (NYSE: AAC), outlined his 2030 vision for the company. At the core of the vision is a scientific approach to take personalized medicine to a new level. Utilizing pharmacogenetics, brain imaging, nutraceuticals and advanced technology, Cartwright believes investing in the latest sciences gives patients struggling with drug and alcohol addiction the best possible outcomes.
"Addiction treatment lags behind many other areas of medicine when it comes to research and innovation," says Cartwright. "This is one of the main reasons why we decided to go public in order to have access to capital to invest in revolutionizing the treatment of this disease."
Dr. Mark Calarco, AAC's national medical director for clinical diagnostics and the CEO of Addiction Labs, worked alongside Cartwright in developing the plan. He has nearly 30 years of experience in both clinical and laboratory medicine.
Calarco explains the science behind the core elements of AAC's 2030 plan. He stresses that the strategies highlighted in the 2030 plan aim to reduce the "trial and error" approach and cognitive bias so prevalent in medicine today.
To better understand the potential impact of brain scans, Calarco points to a recent study featured in HealthDay where scientists were able to identify people with PTSD who were on the brink of suicide based on chemical changes in the brain.
Calarco is excited about AAC's future but doesn't expect everyone to buy into AAC's vision at first. In fact, he says that's a sign AAC is on the right track.
"When things are cutting edge or innovative people often have a hard time getting on board until it's mainstream," he says. "With tens of thousands of people dying every year from this disease, we don't have time to wait on them. We must continue to forge ahead and be the leader in the industry."
About American Addiction Centers
American Addiction Centers (NYSE: AAC) is a leading provider of inpatient and outpatient substance abuse treatment services. We treat clients who are struggling with drug addiction, alcohol addiction, and co-occurring mental/behavioral health issues. We currently operate substance abuse treatment facilities located throughout the United States. These facilities are focused on delivering effective clinical care and treatment solutions. For more information, please find us at AmericanAddictionCenters.org or follow us on Twitter @AAC_Tweet.
Contact
Joy Sutton, 615-727-8407
jsutton@contactaac.com
View original content:http://www.prnewswire.com/news-releases/the-science-behind-the-2030-vision-for-american-addiction-centers-and-how-it-will-revolutionize-the-treatment-of-addiction-300858788.html
SOURCE American Addiction Centers
Copyright 2019 PR Newswire
1 Year Ares Acquisition Chart |
1 Month Ares Acquisition Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions